LOGIN  |  REGISTER
Viking Therapeutics

Recent Insider Transactions - KalVista Pharmaceuticals (NASDAQ: KALV)

Follow NASDAQ:KALV Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ KALV KalVista Pharmaceuticals
Venrock Healthcare Capital Partners III, L.P. / 10 percent owner
04/09/2025
Buy
$9.42
25,000
$236K
5.30M
NASDAQ KALV KalVista Pharmaceuticals
Palleiko Benjamin L / director, officer: CHIEF EXECUTIVE OFFICER
03/07/2025
Sell
$11.97
6,669
$80K
287,811
NASDAQ KALV KalVista Pharmaceuticals
Audhya Paul K. / officer: CHIEF MEDICAL OFFICER
02/24/2025
Sell
$10.02
2,394
$24K
102,940
NASDAQ KALV KalVista Pharmaceuticals
Yea Christopher / officer: CHIEF DEVELOPMENT OFFICER
02/24/2025
Sell
$10.02
1,918
$19K
93,952
NASDAQ KALV KalVista Pharmaceuticals
Yea Christopher / officer: CHIEF DEVELOPMENT OFFICER
02/18/2025
Sell
$9.82
2,601
$26K
92,745
NASDAQ KALV KalVista Pharmaceuticals
Audhya Paul K. / officer: CHIEF MEDICAL OFFICER
02/18/2025
Sell
$9.82
3,125
$31K
100,334
NASDAQ KALV KalVista Pharmaceuticals
Palleiko Benjamin L / director, officer: CHIEF EXECUTIVE OFFICER
02/18/2025
Sell
$9.82
5,104
$50K
278,855

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous